AHA video: New trial design for discharged pulmonary embolism patients suggested

TriMed Staff | | Cardiovascular Business | Vascular & Endovascular
AHA: ADOPT - 90.06 Mb
Samuel Z. Goldhaber, MD, principal investigator of ADOPT, spoke with Cardiovascular Business about the findings of his 2011 AHA late-breaking clinical trial. Image Source: North American Thrombosis Forum
ORLANDO, Fla.—Samuel Z. Goldhaber, MD, principal investigator of ADOPT, discussed the design and negative findings of the trial, which compared an extended course of thromboprophylaxis with apixaban (Eliquis, Bristol-Myers Squibb) with enoxaparin (Lovenox, Sanofi-Aventis) for medically ill patients with venous thromboembolism with Cardiovascular Business.

While the findings from ADOPT were negative, mainly due to the underpowered nature of the trial, Goldhaber recommended a new trial design that could potentially produce stronger results from a properly powered trial. This trial was presented Nov. 13 as a late-breaking clinical trial at the American Heart Association (AHA) scientific sessions.

This video was conducted collaboratively with ClinicalTrialResults.org.

TriMed Staff

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."